Document ID: chunk:federal_register_of_legislation:F2023L00223:clause:1_131
Version: federal_register_of_legislation:F2023L00223
Segment Type: clause
Provision Reference: sch 1 cl 131
Character Range: 87167–88297

131     Where diabetes has led to secondary impairment of renal function, that impairment should be assessed using Chapter 10 – The urinary system.
    132     Using the combined values chart (see Appendix 1), WPI ratings derived under Table 3.1: Thyroid and parathyroid glands and Table 3.2: Adrenal cortex and medulla may be combined with WPI ratings from Table 3.3: Pancreas (diabetes mellitus).
    133     Microangiopathy may be manifest as retinopathy (background, proliferative, or maculopathy) and/or albuminuria measured with a timed specimen of urine. Where there is an overnight collection, the upper limit of normal is 20µg/minute. Where a 24 hour specimen is collected, the upper limit of normal is 30mg/day. Albuminuria must be documented in at least two out of three consecutive urine specimens collected.
Table 3.3: Pancreas (diabetes mellitus)
See notes to Table 3.3 for further information.

%WPI  Type    Therapy                                                                                                                                                                           Microvascular complications